Chair
David A. Relman, M.D.
Associate Professor of Medicine and Associate Professor of Microbiology, Stanford University
Stanford, CA

Vice-Chair
James M. Hughes, M.D. (IOM)
Director, Program in Global Infectious Diseases; Associate Director, Southeastern Center for Emerging Biologic Threats, Emory University
Atlanta, GA

David Acheson, M.D.
Chief Medical Officer and Assistant Commissioner for Food Safety, Food and Drug Administration
Washington, DC

Ruth Berkelman, M.D. (IOM)
Professor, Department of Epidemiology, Rollins School of Public Health, Emory University
Atlanta, GA

Roger Breeze, D.V.M., Ph.D.
Chief Executive Officer, Centaur Science Group
Washington, DC

Enriqueta Bond, Ph.D. (IOM)
Consultant
Marshall, VA

Steven J. Brickner, Ph.D.
SJ Brickner Consulting, LLC.
Ledyard, CT

John E. Burris, Ph.D.
President, Burroughs Wellcome Fund
Research Triangle Park, NC                                                                                                                                                                      
Gail H. Cassell, Ph.D. (IOM)
Vice President, Infectious Diseases, Drug Discovery Research & Clinical Investigation, Eli Lilly and Company
Indianapolis, IN

Mark Feinberg, M.D., Ph.D.
Vice President, Policy, Public Health and Medical Affairs, Merck Vaccines
West Point, PA

Darrell R. Galloway, Ph.D.
Chief, Medical S&T Division (CBM) Chemical & Biological Defense Directorate Joint Science & Technology Office, Defense Threat Reduction Agency
Ft. Belvoir, VA

S. Elizabeth George, Ph.D.
Director, Biological and Chemical Countermeasures Program, Department of Homeland Security
Washington, DC

Jesse L. Goodman, M.D., M.P.H. (IOM)
Director, Center for Biologics Evaluation and Research, Food and Drug Administration
Rockville, MD

Eduardo Gotuzzo, M.D.
Director, Instituto de Medicina Tropical, Universidad Peruana Cayetano Herediam
Lima, Peru

Jo Handelsman, Ph.D.
Professor of Plant Biology, College of Agricultural and Life Sciences
University of Wisconsin
Madison, WI

Carole A. Heilman, Ph.D.
Director, Division of Microbiology and Infectious Disease, National Institutes of Allergy and Infectious Diseases, National Institutes of Health
Bethedsa, MD

David Heymann, M.D. (IOM)
Chairman, Health Protection Agency (Central Office) 
London, England

Phil Hosbach, Ph.D.
Vice President for New Products and Immunization Policy, Sanofi Pasteur
Swiftwater, PA

Stephen Johnston, Ph.D.
Director, Center for Innovations in Medicine, Biodesign Institute, Arizona State University
Tempe, AZ

Kent Kester, M.D.                                                            
Commander, Walter Reed Army Institute of Research
US Army Medical Research and Materiel Command
Silver Spring, MD

Gerald Keusch, M.D. (IOM)
Assistant Provost for Global Health, Medical Center, and Associate Dean for Global Health, Boston University School of Public Health
Boston, MA

Rima Khabbaz, M.D.
Director, National Center for Preparedness, Detection and Control of Infectious Diseases
Centers for Disease Control and Prevention
Atlanta, GA

Lonnie King, D.V.M. (IOM)
Director, Center for Zoonotic, Vectorborne, and Enteric Diseases, Centers for Disease Control and Prevention
Atlanta, GA

Stanley M. Lemon, M.D.
Director, Institute for Human Infections and Immunity, University of Texas Medical Branch
Galveston, TX

Edward McSweegan, Ph.D.
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, MD

Paul Miller, Ph.D.
Pfizer Inc.
Groton, CT.

Stephen S. Morse, Ph.D.
Professor of Clinical Epidemiology, Mailman School of Public Health, Columbia University
New York, NY

Michael T. Osterholm, Ph.D., M.P.H. (IOM)
Director, Center for Infectious Disease Research and Policy, University of Minnesota
Minneapolis, MN

George Poste, D.V.M., Ph.D, D.Sc., F.R.S.
Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University- SkySong
Scottsdale, AZ

John Pottage, M.D.
Senior Vice President, Infectious Diseases Medicine Development Center, GlaxoSmithKline
Collegeville, PA

Gary Roselle, M.D.
Chief of Medical Service, Veterans Administration Medical Center, Program Director for Infectious Disease, Veterans Administration Headquarters
Cincinnati, OH

Kevin L. Russell, M.D.
Director, DOD Global Emerging Infections Surveillance and Response Systems, Walter Reed Army Institute of Research
Silver Spring, MD

Janet Shoemaker
Director, Office of Public Affairs, American Society for Microbiology
Washington, DC

P. Frederick Sparling, M.D.
J. Herbert Bate Professor, Medicine and Microbiology & Immunology, University of North Carolina
Chapel Hill, NC

Terence Taylor
Director, International Council for the Life Sciences and Vice President of Global Health and Security Initiative, Nuclear Threat Initiative
Washington, DC

Murray Trostle, Dr.P.H.
Deputy Director, Avian Influenza Preparedness and Response Unit
USAID
Washington ,DC

Liaison
Yves Bergevin, Ph.D.
Chief, Health Section (H8A), Programme Division, UNICEF
New York, NY